While these recent studies have sparked enthusiasm, Adam Bisaga, MD, professor of clinical psychiatry at Columbia University Vagelos College of Physicians and Surgeons, told Healio that the therapeutic use of these agents for SUDs is not yet robust enough to justify widespread promotion. In fact, there is an inherent danger in overstating potential benefits with low risks, setting unrealistic expectations, and allowing commercial interests to overshadow solid addiction science, he said
You won't get the single-use pens you normally get when you get a prescription for name-brand GLP-1's
PubMed laboratory research record [PMID: 40802953] PubMed record related to this compound for laboratory literature review
Frequently Asked Questions Is Mounjaro available on the NHS for weight loss
Absorption, Safety, and Detoxification Effects of Oral Liposomal Glutathione
Today, the SURMOUNT-5 Data Dropped Back